Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures
Radiation Research · 15.04.2024 · 201 (6) · 628-646
DOI: 10.1667/rade-23-00196.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Research, erschienen am 15.04.2024. Verfasst von Thomas A Winters und 11 weiteren Autor:innen. Beteiligte Einrichtung: Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and I…. Hauptthemen laut MEDLINE: Acute Radiation Syndrome, Biomarkers, Medical Countermeasures. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
There have been a number of reported human exposures to high dose radiation, resulting from accidents at nuclear power plants (e.g., Chernobyl), atomic bombings (Hiroshima and Nagasaki), and mishaps in industrial and medical settings. If absorbed radiation doses are high enough, evolution of acute radiation syndromes (ARS) will likely impact both the bone marrow as well as the gastrointestinal (GI) tract. Damage incurred in the latter can lead to nutrient malabsorption, dehydration, electrolyte imbalance, altered microbiome and metabolites, and impaired barrier function, which can lead to septicemia and death. To prepare for a medical response should such an incident arise, the National Institute of Allergy and Infectious Diseases (NIAID) funds basic and translational research to address radiation-induced GI-ARS, which remains a critical and prioritized unmet need. Areas of interest include identification of targets for damage and mitigation, animal model development, and testing of medical countermeasures (MCMs) to address GI complications resulting from radiation exposure. To appropriately model expected human responses, it is helpful to study analogous disease states in the clinic that resemble GI-ARS, to inform on best practices for diagnosis and treatment, and translate them back to inform nonclinical drug efficacy models. For these reasons, the NIAID partnered with two other U.S. government agencies (the Biomedical Advanced Research and Development Authority, and the Food and Drug Administration), to explore models, biomarkers, and diagnostics to improve understanding of the complexities of GI-ARS and investigate promising treatment approaches. A two-day workshop was convened in August 2022 that comprised presentations from academia, industry, healthcare, and government, and highlighted talks from 26 subject matter experts across five scientific sessions. This report provides an overview of information that was presented during the conference, and important discussions surrounding a broad range of topics that are critical for the research, development, licensure, and use of MCMs for GI-ARS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockv…
- Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland.
- Office of Regulatory Affairs, DAIT, NIAID, NIH, Rockville, Maryland.
- Center for Devices for Radiological Health (CDRH), FDA, Silver Spring, Maryland.
- Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC.
Förderung
- Intramural NIH HHS
Zitieren
APA
Winters, T. A., Marzella, L., Molinar-Inglis, O., Price, P. W., Han, N. C., Cohen, J. E., Wang, S. J., Fotenos, A. F., Sullivan, J. M., Esker, J. I., Lapinskas, P. J., & DiCarlo, A. L. (2024). Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures. Radiation Research, 201(6), 628-646. https://doi.org/10.1667/rade-23-00196.1
Vancouver
Winters TA, Marzella L, Molinar-Inglis O, Price PW, Han NC, Cohen JE, et al. Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures. Radiation Research. 2024;201(6):628-646. doi:10.1667/rade-23-00196.1
BibTeX
@article{Winters2024,
author = {Winters, Thomas A and Marzella, Libero and Molinar-Inglis, Olivia and Price, Paul W and Han, Nyun Calvin and Cohen, Jonathan E and Wang, Sue-Jane and Fotenos, Anthony F and Sullivan, Julie M and Esker, John I and Lapinskas, Paula J and DiCarlo, Andrea L},
title = {Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures},
journal = {Radiation Research},
year = {2024},
volume = {201},
number = {6},
pages = {628--646},
doi = {10.1667/rade-23-00196.1}
}
EUVIMED